QCM
IRMD icon

Quantinno Capital Management’s iRadimed IRMD Stock Holding History

Quantinno Capital Management’s Portfolio IRMD Stock Details IRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$588K Buy
6,148
+2,666
+77% +$243K ﹤0.01% 2901
2026
Q1 		$335K Buy
3,482
+387
+13% +$38.7K ﹤0.01% 2975
2025
Q4 		$301K Buy
+3,095
New +$266K ﹤0.01% 2828

Other funds holding IRMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.87B AUM 31.21% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $321M AUM 44.58% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Quantinno Capital Management's IRMD Position: Q2 2026 in Review

Quantinno Capital Management increased its iRadimed (IRMD) stake by 77% in Q2 2026, buying an estimated $243K and bringing the position to 6,148 shares worth $588K. The position accounts for ﹤0.01% of the portfolio, ranked #2901.

Quantinno Capital Management first reported a position in IRMD in Q4 2025 and has held it in 3 quarters since. 214 funds tracked by Wall St. Rank hold IRMD as of Q2 2026.

  • Quantinno Capital Management held 6,148 shares of iRadimed worth $588K as of Q2 2026.
  • Quantinno Capital Management bought 2,666 iRadimed shares in Q2 2026, an estimated $243K.
  • iRadimed made up ﹤0.01% of Quantinno Capital Management's portfolio in Q2 2026, its #2901 holding.
  • Quantinno Capital Management first reported a position in iRadimed in Q4 2025 and has held it in 3 quarters since.
  • 214 funds tracked by Wall St. Rank held iRadimed as of Q2 2026.

Based on Quantinno Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.